Related Experiment Video
Updated: Jul 10, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
[Research on human ovarian cancer cell MDR1 gene silenced by siRNA]
Jiang-yan Lou1, Zhi-lan Peng, Ying Zheng
1Department of Obsterics and Gynecology, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To evaluate the effects of siRNA on the inhibitions of mRNA and P-gp expression of ovarian cancer cell with high expression of multidrug resistance gene (MDR1).
Methods:
The siRNA was transferred into ovarian cancer cell line OVCAR8/TR. The real time RT-PCR and flow cytometry were used respectively to determine the expression of mRNA or P-gp of MDR1.
Results:
The inhibition of mRNA-84% expression occurred at 48 h after cell transfection, and the inhibition of P-gp-85.23% expression occurred at 72 h after cell transfection. Afterward the inhibitions to mRNA and P-gp expressions gradually returned to the normal levels. The amounts of mRNA and P-gp expression had no difference between negative control and untransfected cells.
Conclusion:
RNA interference presents in the human ovarian cancer cell, siRNA can effectively inhibit the expression of mRNA and P-gp of MDR1. The RNAi may represent a new approach for the treatment of MDR1-mediated drug resistance.
Insights
Small interfering RNA (siRNA) effectively inhibits multidrug resistance gene 1 (MDR1) mRNA and P-glycoprotein (P-gp) expression in ovarian cancer cells. This RNA interference approach shows promise for overcoming drug resistance in cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Multidrug resistance (MDR) is a significant challenge in ovarian cancer treatment.
- The multidrug resistance gene 1 (MDR1) and its product P-glycoprotein (P-gp) are key mediators of MDR.
- Targeting MDR1 expression offers a potential strategy to overcome drug resistance.
Purpose of the Study:
- To evaluate the efficacy of small interfering RNA (siRNA) in inhibiting MDR1 mRNA and P-gp expression.
- To assess the impact of siRNA on multidrug resistance in an ovarian cancer cell line.
Main Methods:
- Ovarian cancer cell line OVCAR8/TR was transfected with siRNA.
- Real-time RT-PCR was used to quantify MDR1 mRNA expression.
- Flow cytometry was employed to determine P-gp expression levels.
Main Results:
- siRNA transfection resulted in significant inhibition of MDR1 mRNA (84% at 48 hours) and P-gp (85.23% at 72 hours) expression.
- Inhibited expression levels gradually returned to normal over time.
- No significant difference in expression was observed between negative control and untransfected cells.
Conclusions:
- RNA interference using siRNA effectively suppresses MDR1 mRNA and P-gp expression in human ovarian cancer cells.
- This RNA interference strategy presents a potential new therapeutic approach for MDR1-mediated drug resistance in ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
